TOPIC

CHINESE STOCKS News & Analysis

A leading fund manager finds gems amid China rubble
Markets
A leading fund manager finds gems amid China rubble
Platinum Asset Management’s CEO tells Morningstar’s Wealth of Experience podcast that as China’s economy tanks and investors flee, he’s finding some...
James Gruber | 23 August 2023
China’s travel stocks are benefitting from Covid-19 relaxations
Stocks
China’s travel stocks are benefitting from Covid-19 relaxations
But a V-shaped recovery like the one seen in 2021 is very unlikely in 2023.
Kate Lin | 23 November 2022
Are battered China tech stocks on a long-term rebound?
Stocks
Are battered China tech stocks on a long-term rebound?
\nChinese stocks, including Alibaba, have staged a big rebound. Here's what it might take for the rally to continue\n
Kate Lin | 20 July 2022
Equity market outperformance lures some investors back to China
Stocks
Equity market outperformance lures some investors back to China
Government stimulus and cheap valuations are changing the risk/reward equation for Chinese equities, say fund managers.
Nicki Bourlioufas | 11 July 2022
Chinese wide-moat stocks at a discount
Stocks
Chinese wide-moat stocks at a discount
Some of Asia's best companies like Tencent and Alibaba have fallen deep into undervalued territory amid recent share price turmoil.
Kate Lin | 16 March 2022
Year of the Tiger: What's next for Chinese stocks
Stocks
Year of the Tiger: What's next for Chinese stocks
The Chinese lunar year is almost over, and what a ride it's been. Morningstar speaks to JPMorgan Asset Management strategist Mike Bell about what's...
Lukas Strobl | 31 January 2022
Chinese equities offer value, but risks lie ahead
Stocks
Chinese equities offer value, but risks lie ahead
Regulatory changes led to a mass selloff of Chinese equities throughout the year.
Nicki Bourlioufas | 08 December 2021
Chinese tech giant Alibaba falls from grace
Stocks
Chinese tech giant Alibaba falls from grace
Morningstar analysts like its competitor, e-commerce giant JD.com
Kate Lin | 25 November 2021
6 global equity names for your portfolio
Markets
6 global equity names for your portfolio
Three wide-moat dividend payers and three non-tech Chinese stocks.
Lewis Jackson | 14 September 2021
Chinese biotech: Buy the dip?
Stocks
Chinese biotech: Buy the dip?
Morningstar looks at two diversified Chinese biotech names.
Kate Lin | 07 September 2021